JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Other Current Assets
JW (Cayman) Therapeutics Co Ltd
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Other Current Assets
¥18.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Other Current Assets
¥1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Other Current Assets
¥1.3B
|
CAGR 3-Years
78%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Other Current Assets
¥74.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Other Current Assets
¥122.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
41%
|
CAGR 10-Years
33%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Other Current Assets
¥20.9m
|
CAGR 3-Years
31%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Other Current Assets?
Other Current Assets
18.8m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Other Current Assets amounts to 18.8m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-13%
Over the last year, the Other Current Assets growth was 0%. The average annual Other Current Assets growth rates for JW (Cayman) Therapeutics Co Ltd have been 11% over the past three years , -13% over the past five years .